CommercialCoverageMedium impact
08.01.25i, Ramucirumab (Cyramza®)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Aug 18, 2025
We identified it
Jun 19, 2026
Summary
Updated medical necessity criteria, coding guidelines, and general information for Ramucirumab (Cyramza®), a cancer treatment medication. This affects pharmacy benefit coverage and may impact prior authorization requirements or billing procedures for oncology practices.
Action Required
By August 18, 2025: Billing team must review updated medical necessity criteria for Ramucirumab (Cyramza®) prescriptions. Update prior authorization workflows and documentation requirements for oncology patients receiving this cancer treatment. Verify current coding guidelines are being followed to prevent claim denials.